The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant

$ 11.00

4.5
(346)
In stock
Description

Biomolecules, Free Full-Text

Cancers, Free Full-Text

Emerging insights into mechanisms of trastuzumab resistance in

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in

Detailed curriculum vitae of HER2-targeted therapy - ScienceDirect

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in

Cancers, Free Full-Text

An ErbB-2 molecule unable to bind Hsp90 shows enhanced activity

Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in

Transcriptomic analysis with HER2 and 611-CTF. (A) Venn diagram

PDF) A novel HSP90 inhibitor SL-145 suppresses metastatic triple